Newsletter - August 24, 2023
Pharma Connections in Patient Advocacy Leadership Raises Conflict of Interest Concerns
Patient advocacy organizations (PAOs) have a vital role in raising awareness about diseases and representing patient interests with the industry and FDA. In the last few years, PAOs played a critical role in raising patients’ opinions about controversial new drugs with the FDA, in turn leading to the approval...Read More
Should the FDA Increase Dietary Supplement Review
Unlike pharmaceuticals, supplement ingredients don't undergo FDA preapproval for effectiveness or safety prior to market introduction. This regulatory gap has paved the way for manufacturers to overlook basic manufacturing standards, resulting in compromised product quality. The identity, purity and...Read More
Pharma Connections in Patient Advocacy Leadership Raises Conflict of Interest Concerns
Patient advocacy organizations (PAOs) have a vital role in raising awareness about diseases and representing patient interests with the industry and FDA. In the last few years, PAOs played a critical role in raising patients’ opinions about controversial new drugs with the FDA, in turn leading to the approval...Read More
Should the FDA Increase Dietary Supplement Review
Unlike pharmaceuticals, supplement ingredients don't undergo FDA preapproval for effectiveness or safety prior to market introduction. This regulatory gap has paved the way for manufacturers to overlook basic manufacturing standards, resulting in compromised product quality. The identity, purity and...Read More
